SCIENTIFIC PROGRAM
timetable | Preliminary Program Schedule
WEDNESDAY, October 26
08.00 Registration open
14.00 Courses, Societies meetings
17.15 Welcome Message
17.20 Plenary Lecture 1
17.40 Plenary Lecture 2

FRIDAY, October 28
08.30 Parallel sessions
09.45 Plenary Lecture 6
10.05 Plenary Lecture 7
10.25 Plenary Lecture 8
11.30 Sponsored Symposium
12.45 Parallel sessions
14.15 Sponsored Symposia
15.30 Parallel sessions
17.15 Sponsored Symposium
18.15 Parallel sessions
THURSDAY, October 27
08.30 Parallel sessions
09.45 Plenary Lecture 3
10.05 Plenary Lecture 4
10.25 Plenary Lecture 5
11.30 Sponsored Symposium
12.45 Parallel sessions
14.15 Sponsored Symposia
15.30 Parallel sessions
17.15 Sponsored Symposium
18.15 Parallel sessions

SATURDAY, October 29
08.30 Plenary session
10.15 Parallel sessions
11.25 Plenary Lecture 9
11.45 Plenary Lecture 10
12.20 Plenary Lecture 11
12.40 Plenary Lecture 112
13.00 Closing Ceremony
MAIN SPEAKERS
Boris C. Bastian
  • Gerson and Barbara Bass Bakar Distinguished Professor in Cancer Research, UCSF
  • Professor of Dermatology and Pathology, University of California, San Francisco
Reinhard Dummer (Germany)
  • Professor of the University of Zurich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland and is a key thought leader in worldwide cutaneous oncology. Currently he is heading of the Skin Cancer Unit and the Clinical Trial Unit of the Department of Dermatology.
Claus Garbe (Germany)
  • University Professor of Dermatology at Eberhard Karls University, Germany, where he is also Head of the division of Dermato-oncology.
  • Head of the Interdisciplinary Skin Tumor Centre and Head of the German Central Malignant Melanoma Registry.
Allan C. Halpern (USA)
  • Chief, Dermatology Service, Memorial Sloan Kettering
  • Cancer Center, New York City
Henry W. Lim (USA)
  • Henry Ford Health
  • Program Director, Dermatology Research, C.S. Livinggood
  • Program Director, Photomedicine Fellowship
  • Specialize in vitiligo, psoriasis, allergic reaction to sunlight (photosensitivity), eczema, and cutaneous T-cell lymphoma (skin cancer)
Josep Malvehy (Spain)
  • Director of the Skin Cancer Unit
  • Consultant of the Dermatology Service of Hospital Clínic. University of Barcelona. Spain
  • Associate professor at the Faculty of Medicine of the University of Barcelona
  • Researcher at the "Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS)"
Je-Ho Mun (South Korea)
  • Associate Professor, Department of Dermatology, Seoul National University Hospital
  • Department of Dermatology, Seoul National University College of Medicine
Uli Osterwalder (Switzerland)
  • Sun Protection Facilitator GmbH. Basel, Switzerland
  • Independent scientific and technical advisor in Sun Protection. Chair of ISO TC 217 (Cosmetics).
  • Scientific autor Sun Protection Facilitator GmbH and is committed to contribute to further improvements in sun protection. Uli Osterwalder works for ISO on the development of new UV protection assessment methods and is author and co-author of numerous scientific articles and book chapters on sun protection.
Manish Patel (USA)
  • Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation
  • University of Minnesota, Minneapolis, MN
    Medical School
Giovanni Pellacani (Italy)
  • Chairman of the Dermatology Clinic and Director of the School of Dermatology of the University La Sapienza, Roma
  • He practices research mainly in the field of cutaneous physiopathology, skin bio-engineering for the evaluation of inflammatory diseases, non-invasive diagnosis in dermato-oncology, since 1995.
Susana Puig Sardá (Spain)
  • Head of the Dermatology Service of the Hospital Clínic de Barcelona
  • Dermatology specialist at barnaclínic
  • Leader of the IDIBAPS "Melanoma: Imaging, Genetics and Immunology" research group
  • Professor at the University of Barcelona
Deborah S. Sarnoff (USA)
  • Clinical professor of dermatology, Ronald O. Perelman
  • Department of Dermatology, NYU School of Medicine
José Antonio Sanches (Brazil)
  • He is a professor at the Faculty of Medicine of the University of São Paulo. He has experience in Medicine, with an emphasis on Clinical Dermatology, working mainly in the area of Cutaneous Oncology, paraneoplasms and skin eruptions caused by antineoplastic agents.
  • Coordinator of the Cutaneous Lymphoma Group at the Hospital das Clínicas, Faculty of Medicine, USP
Sérgio Schalka (Brazil)
  • Coordinator of the Brazilian Consensus on Photoprotection
  • Chairman of the Latin American Photoprotection Alliance
  • USP Associate Researcher
  • Specialist in Photoprotection
  • Managing Partner of Grupo Medcin
Rafael Aron SCHMERLING (Brazil)
  • Coordinator of the Brazilian Consensus on Photoprotection
  • Chairman of the Latin American Photoprotection Alliance
  • USP Associate Researcher
  • Specialist in Photoprotection
  • Managing Partner of Grupo Medcin
Chrysalyne D. Schmults (USA)
  • Vice Chair, Surgical Oncology, Department of Dermatology Program Director, Micrographic Surgery and Dermatologic Oncology Fellowship Program
  • Associate Professor, Harvard Medical School
Peter Soyer (Australia)
  • Academic dermatologist with over 30 years’ experience in the field. He was appointed as the inaugural Chair in Dermatology by The University of Queensland (UQ) in 2007 and as Director of the Princess Alexandra Hospital (PAH) Dermatology Department in 2008. He has a strong focus on translational skin cancer research in his dual role as Director of the Dermatology Research Centre (DRC), UQ Diamantina Institute, UQ Faculty of Medicine; and leadership of the Dermatology Department at the Princess Alexandra Hospital in Brisbane.
Rolf-Markus Szeimies (Germany)
  • Klinikum Vest GmbH
  • Dermatology & Allergology
  • Head of Department
  • Academic teaching. Ruhr Universität. Bochum
Vernon Sondak, MD (USA)
  • Chair, Department of Cutaneous Oncology
  • Specialty: Surgery
  • Program: Cutaneous Oncology
Richard Scolyer (Australia)
  • Conjoint Professor, FMH Translational Research Collective
  • Co-Medical Director, Melanoma Institute Australia
  • Senior Staff Specialist (Melanoma), Royal Prince Alfred Hospital and NSW Health Pathology
Main Sessions
  • Advanced BCC management
  • Controversies in Skin Cancer
  • Cutaneous lymphoma
  • Cutaneous toxicity of systemic oncologic therapy
  • Dermato-Oncology in Latin America
  • Dermoscopy
  • Dermoscopy Course
  • Ex vivo confocal microscopy in fast evaluation - Mohs surgery
  • Field cancerization
  • First experiences with a Telehealth Network for Melanoma Surveillance in Australia
  • GBM - Grupo Brasileiro de Melanoma
  • Grupo Argentino de Linfomas Cutáneos (GALIC)
  • High risk Squamous Cell Carcinoma
  • How to identify patient with high risk melanoma? and how to manage them?
  • Is pathology the gold standard for melanoma diagnosis? (PRE-RECORDED)
  • Management of high risk early stage melanoma
  • Merkel cell carcinoma and other rare tumors
  • Merkel Cell Carcinoma: Update and challenges
  • Mohs surgery
  • New technologies in Melanoma diagnosis
  • Obstacles in melanoma prevention (why it does not work)
  • Pathogenesis of melanoma: evolution from precursor lesions
  • Photoprotection, skin cancer and cutaneous toxicities (AVENE)
  • Running a Cancer Center
  • Skin Cancer in Latin America
  • Skin cancer in the immunosuppressed patient
  • Skin Cancer Pathology
  • Sociedad de Mohs - LATAM
  • Systemic management of advanced melanoma
  • The future of sunscreens
  • Updates of the WHO classification: how many melanomas subtypes are there?